Smith, Moore & Co’s HCA Healthcare HCA Stock Holding History

Smith, Moore & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Buy	847 +12	+1%	+$5.07K	0.02%	437
2026 Q1	$395K	Buy	835 +100	+14%	+$50.3K	0.03%	371
2025 Q4	$343K	Sell	735 -5	-0.7%	-$2.32K	0.03%	387
2025 Q3	$315K	Hold	740	–	–	0.02%	393
2025 Q2	$283K	Hold	740	–	–	0.02%	405
2025 Q1	$256K	Sell	740 -15	-2%	-$4.82K	0.02%	408
2024 Q4	$227K	Hold	755	–	–	0.02%	432
2024 Q3	$307K	Hold	755	–	–	0.03%	357
2024 Q2	$243K	Hold	755	–	–	0.03%	388
2024 Q1	$252K	Sell	755 -1	-0.1%	-$306	0.03%	373
2023 Q4	$205K	Buy	+756	New	+$187K	0.02%	392
2023 Q3	–	Sell	-751	Closed	-$228K	–	387
2023 Q2	$228K	Buy	+751	New	+$209K	0.03%	355
2022 Q2	–	Sell	-900	Closed	-$226K	–	406
2022 Q1	$226K	Hold	900	–	–	0.03%	371
2021 Q4	$231K	Hold	900	–	–	0.03%	371
2021 Q3	$218K	Buy	+900	New	+$220K	0.03%	371
2021 Q1	–	Sell	-2,284	Closed	-$376K	–	398
2020 Q4	$376K	Hold	2,284	–	–	0.07%	232
2020 Q3	$285K	Buy	2,284 +150	+7%	+$18.6K	0.06%	258
2020 Q2	$207K	Buy	+2,134	New	+$222K	0.05%	296
2020 Q1	–	Sell	-2,134	Closed	-$315K	–	310
2019 Q4	$315K	Sell	2,134 -100	-4%	-$13.4K	0.07%	246
2019 Q3	$269K	Hold	2,234	–	–	0.06%	265
2019 Q2	$302K	Hold	2,234	–	–	0.07%	258
2019 Q1	$291K	Hold	2,234	–	–	0.07%	248
2018 Q4	$278K	Hold	2,234	–	–	0.08%	245
2018 Q3	$311K	Hold	2,234	–	–	0.07%	246
2018 Q2	$229K	Hold	2,234	–	–	0.06%	287
2018 Q1	$217K	Buy	+2,234	New	+$217K	0.06%	284

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Smith, Moore & Co's HCA Position: Q2 2026 in Review

Smith, Moore & Co increased its HCA Healthcare (HCA) stake by 1.4% in Q2 2026, buying an estimated $5.07K and bringing the position to 847 shares worth $330K. The position accounts for 0.02% of the portfolio, ranked #437.

Smith, Moore & Co first reported a position in HCA in Q1 2018 and has held it in 26 quarters since. The position peaked at $395K in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Smith, Moore & Co held 847 shares of HCA Healthcare worth $330K as of Q2 2026.
Smith, Moore & Co bought 12 HCA Healthcare shares in Q2 2026, an estimated $5.07K.
HCA Healthcare made up 0.02% of Smith, Moore & Co's portfolio in Q2 2026, its #437 holding.
Smith, Moore & Co first reported a position in HCA Healthcare in Q1 2018 and has held it in 26 quarters since.
Smith, Moore & Co's HCA Healthcare position peaked at $395K in Q1 2026.
1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.